Literature DB >> 12374680

Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.

Masahide Ikeguchi1, Tsuyoshi Ueta, Yoshiaki Yamane, Yasuaki Hirooka, Nobuaki Kaibara.   

Abstract

PURPOSE: Proliferative activity and suppression of apoptosis of cancer cells are important to tumor progression in hepatocellular carcinoma (HCC). Recently, the expressions of inducible nitric oxide synthase (iNOS) and survivin mRNA have been reported to correlate with suppression of apoptosis in some tumors. However, the clinical importance of expression of these genes in HCC progression remains unclear. In the present study, the correlation between the expression of iNOS and survivin mRNA and the occurrence of spontaneous apoptosis and proliferative activity of cancer cells and prognostic importance of expression of these genes in HCC were investigated. EXPERIMENTAL
DESIGN: Tissues were obtained by surgical resection of livers from 61 patients with HCC and 8 without HCC. Expressions of iNOS and survivin mRNA were evaluated using the reverse transcription-PCR in 61 tumors, 61 adjacent histologically noncancerous livers, and 8 normal livers. Apoptotic cancer cells and the proliferative activity of cancer cells were detected by immunohistochemistry.
RESULTS: iNOS mRNA expression was detected in 34 of 61 (55.7%) HCCs, 19 of 61 (31.1%) noncancerous liver tissues adjacent to carcinoma, and none of the 8 normal livers. In addition, survivin mRNA was detected in 19 of 61 (31.1%) HCCs, none of 61 noncancerous liver tissues, and none of the 8 normal livers. iNOS mRNA expression did not correlate with the proliferative activity of cancer cells or with the occurrence of apoptosis in HCCs. In contrast, survivin mRNA expression strongly correlated with a high proliferative activity of cancer cells and a low apoptotic index. Disease-specific survivals did not differ between patients with iNOS-positive or -negative HCCs. Although, the disease-specific survival of patients with survivin-positive HCCs was significantly poorer than that of patients with survivin-negative HCCs.
CONCLUSIONS: These results indicate that iNOS may not correlate with cancer cell-proliferative activity or apoptosis; survivin, however, may not only suppress apoptosis but also accelerate cancer cell-proliferative activity and play an important role in tumor progression in HCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374680

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  27 in total

1.  Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma.

Authors:  Chao-Ping Ye; Cheng-Zhi Qiu; Zhong-Xin Huang; Qi-Chen Su; Wei Zhuang; Rui-Lan Wu; Xin-Feng Li
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

2.  Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation.

Authors:  Rajesh Kannangai; Jianzhou Wang; Qiong Z Liu; Fikret Sahin; Michael Torbenson
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 3.  Regulation of DNA repair by S-nitrosylation.

Authors:  Chi-Hui Tang; Wei Wei; Limin Liu
Journal:  Biochim Biophys Acta       Date:  2011-05-05

4.  Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.

Authors:  Kshitij Srivastava; Anvesha Srivastava; Balraj Mittal
Journal:  Mol Biol Rep       Date:  2011-05-26       Impact factor: 2.316

5.  Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells.

Authors:  Hongtao Guo; Carlos E Marroquin; Philip Y Wai; Paul C Kuo
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

6.  β-Cyclodextrin modified Pt(II) metallacycle-based supramolecular hyperbranched polymer assemblies for DOX delivery to liver cancer cells.

Authors:  Wenzhuo Chen; Xuefeng Li; Chengfei Liu; Jia He; Miao Qi; Yue Sun; Bingbing Shi; Hajar Sepehrpour; Hui Li; Wei Tian; Peter J Stang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

7.  Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.

Authors:  Haipeng Wang; Shengjian Jin; Huiling Lu; Sisi Mi; Wenhua Shao; Xiaoxv Zuo; Huangyi Yin; Sien Zeng; Fumio Shimamoto; Guangying Qi
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

8.  Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation.

Authors:  Jin Hee Lee; Thomas Palaia; Louis Ragolia
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-03       Impact factor: 4.249

9.  Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition.

Authors:  Chi-Hui Tang; Wei Wei; Martha A Hanes; Limin Liu
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

Review 10.  Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.

Authors:  Graciele Almeida de Oliveira; Robert Y S Cheng; Lisa A Ridnour; Debashree Basudhar; Veena Somasundaram; Daniel W McVicar; Hugo Pequeno Monteiro; David A Wink
Journal:  Antioxid Redox Signal       Date:  2016-10-31       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.